Characterization of an air-liquid interface primary human vaginal epithelium to study Ebola virus infection and testing of antivirals

Ebola virus (EBOV) is the causative agent of the often-fatal Ebola virus disease (EVD) characterized by hemorrhagic fever in humans and non-human primates. Sexual transmission from male survivors has been at the origin of multiple outbreak flare-ups between 2015 and 2021. However, this route is still poorly understood and the resulting EVD from it is also understudied. To support epidemiological studies documenting sexual transmission to women, and as a transition from previously using monolayer vaginal epithelial cells (VK2/E6E7), we first determined the biological relevance of two similar air-liquid interface models of the human vaginal epithelium (VEC and VLC Epivaginal™) and then characterized their susceptibility to EBOV and virus-induced inflammation. Finally, we evaluated toxicity of Polyphenylene Carboxymethylene (PPCM) microbicide in VLC and reassessed its antiviral effect. As expected, the VEC, but also VLC model showed stratified layers including a lamina propria under an epithelial structure similar to the full thickness of the human vaginal epithelium. However, we could not detect the immune cells featured in the most relevant model (VLC) of the vaginal epithelium using the dendritic cell CD1a and CD11c markers. Consistent with our previous work using the VK2/E6E7 cell line, infectious virus was detected from the apical side of both primary human cell systems, but only when using a high infective dose, with titers remaining at a constant level of 103–4 pfu/ml over 7 days suggesting lasting infectious virus shedding. In addition, infection caused disruption of the epithelium of both models and virus antigen was found from the apical superficial layers down to the lamina propria suggesting full virus penetration and overall confirming the susceptibility of the human vaginal tissue for EBOV. Just like previously seen in VK2/E6E7 cells, VLC infection also caused significant increase in inflammatory markers including IL-6, IL-8, and IP-10 suggesting vaginitis which is again consistent with tissue lesions seen in non-human primates. Finally, both virus infection and virus induced inflammatory response in VLC could be prevented by a single 5-min PPCM microbicide treatment prior infection.

EpiVaginal (VEC-100-FT, VLC-100-FT), Ebola virus, Polyphenylene carboxymethylene, viral infection, TEER, cell stimulation assay, Papp, Jurkat cells, macrophage-derived THP-1 (resting M0) cells, Eotaxin, FGF-basic, G-CSF, GM-CSF, IL-1Ra, IL-1b, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12 (p70), IL-13, IL-15, IL-17, IFN-gamma, IP-10, MCP-1, MIP-1a, MIP-1b, RANTES, TNF-a, PDGF-BB, VEGF, transmission electron microscopy, scanning electron microscopy, Ebola virus glycoprotein, anti-viral agent, vaginitis

Vigabatrin, Sabril, Kigabeq, Caffeine, Metoprolol, Propranolol, Sulfadiazine, Tolbutamide, Amiloride, Atenolol, Famotidine, Chlorothiazide, Amdinocillin, Xamoterol, Ganciclovir, Lucifer yellow